Katharine Wright is currently a Senior Scientist at Merck, leveraging over four years of experience in structural biology focused on drug discovery. Previously, they served as a Postdoctoral Research Fellow at Johns Hopkins Medicine, where they elucidated the structural basis of T cell engagers targeting MHC-neoantigens and contributed to the development of immuno-therapeutics. Katharine holds a Ph.D. in Biochemistry from The George Washington University and a B.S. in Chemistry from the University of Scranton. They have a strong background in training and mentoring students across various educational levels.
Location
Plymouth Meeting, United States